Bryn Mawr Trust Advisors LLC Sells 4,488 Shares of Zoetis Inc. $ZTS

Bryn Mawr Trust Advisors LLC trimmed its position in shares of Zoetis Inc. (NYSE:ZTS) by 30.6% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 10,181 shares of the company’s stock after selling 4,488 shares during the quarter. Bryn Mawr Trust Advisors LLC’s holdings in Zoetis were worth $1,490,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of ZTS. Halbert Hargrove Global Advisors LLC lifted its holdings in shares of Zoetis by 496.6% in the 3rd quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock worth $25,000 after acquiring an additional 144 shares during the last quarter. REAP Financial Group LLC raised its position in Zoetis by 201.5% in the 2nd quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock worth $31,000 after purchasing an additional 131 shares during the period. NewSquare Capital LLC lifted its stake in Zoetis by 69.1% in the second quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock worth $32,000 after purchasing an additional 85 shares during the last quarter. Financial Consulate Inc. purchased a new stake in Zoetis during the third quarter valued at about $39,000. Finally, SJS Investment Consulting Inc. boosted its position in Zoetis by 1,606.3% during the third quarter. SJS Investment Consulting Inc. now owns 273 shares of the company’s stock valued at $40,000 after buying an additional 257 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on ZTS shares. Weiss Ratings downgraded Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday. Wall Street Zen raised Zoetis from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. Stifel Nicolaus cut their target price on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a report on Tuesday, November 18th. Bank of America cut shares of Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 target price on the stock. in a report on Monday, December 15th. Finally, UBS Group set a $136.00 price target on shares of Zoetis in a report on Thursday. Five research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $152.45.

Zoetis Stock Up 2.5%

Shares of Zoetis stock opened at $124.79 on Friday. The company has a current ratio of 3.64, a quick ratio of 2.28 and a debt-to-equity ratio of 1.31. Zoetis Inc. has a 12-month low of $115.25 and a 12-month high of $177.40. The company has a market cap of $54.99 billion, a P/E ratio of 21.01, a PEG ratio of 2.10 and a beta of 0.97. The company’s fifty day simple moving average is $124.08 and its two-hundred day simple moving average is $137.15.

Zoetis (NYSE:ZTS) last announced its earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, beating analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The firm had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.42 billion. During the same quarter in the previous year, the firm posted $1.58 EPS. The company’s revenue for the quarter was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Research analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Stockholders of record on Tuesday, January 20th will be given a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, January 20th. This represents a $2.12 annualized dividend and a dividend yield of 1.7%. This is an increase from Zoetis’s previous quarterly dividend of $0.50. Zoetis’s dividend payout ratio is currently 35.69%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.